| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/30/1993 | EP0548200A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/30/1993 | EP0548190A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 06/30/1993 | EP0548138A1 Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof |
| 06/30/1993 | EP0548123A1 Anti-inflammatory factor, method of isolation, and use |
| 06/30/1993 | EP0389509B1 Fowlpox virus promoters |
| 06/30/1993 | CN1073719A Nanbv diagnostics and vaccines |
| 06/30/1993 | CN1073605A Improved tissue glue prepared by using cryoprecipitate |
| 06/30/1993 | CN1073604A Process for preparing higher immunogenic hepatitis B vaccine |
| 06/29/1993 | US5223604 For inhibiting binding of pseudomonas bacteria to epithelial cells or for vaccines to immunize against them |
| 06/29/1993 | US5223441 Receptors for immune complexes |
| 06/29/1993 | US5223427 Synthetic polypeptide |
| 06/29/1993 | US5223426 Monoclonal antibodies reactive with defined regions of the t-cell antigen receptor |
| 06/29/1993 | US5223425 DNA sequence which codes serine protease for diagnosis and/or treatment of obesity or metabolic defects |
| 06/29/1993 | US5223424 Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
| 06/29/1993 | US5223410 Method for production of antibodies utilizing an antigen-free animal |
| 06/29/1993 | US5223396 Measuring intercellular adhesion molecule |
| 06/29/1993 | US5223255 Bordetella pertussis variants |
| 06/29/1993 | US5223254 Polypeptide |
| 06/29/1993 | US5223253 Bovine vaccine compositions and method for preventing trichomonas infections using same |
| 06/29/1993 | CA1319634C Vaccine |
| 06/29/1993 | CA1319629C Fusion proteins |
| 06/29/1993 | CA1319628C Fusion proteins |
| 06/28/1993 | CA2086162A1 Oligonucleotides, oligopeptides and determination system of hcv antibody subtype |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | WO1993012228A1 Method for generating structural and functional diversity in a peptide sequence |
| 06/24/1993 | WO1993012221A1 Association between a human immunodeficiency virus-related retrovirus and autoimmune disease |
| 06/24/1993 | WO1993012145A1 Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| 06/24/1993 | WO1993011795A1 Anti-idiotypic vaccine for protection against bovine respiratory syncytial virus |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011793A1 Use of the combination of anti-tumor necrosis factor plus interleukin-6 to treat septic shock |
| 06/24/1993 | WO1993011792A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 06/24/1993 | WO1993011791A1 Antigenic preparations that stimulate production of antibodies which bind to the pili of type iv piliated bacteria |
| 06/24/1993 | WO1993011790A1 Flea midgut-supernatant vaccines |
| 06/24/1993 | DE4142552A1 Monoklonale antikoerper gegen die typ i phospholipase a(pfeil abwaerts)2(pfeil abwaerts) als entzuendungshemmendes therapeutikum Monoclonal antibodies against type I phospholipase A (down arrow) 2 (down arrow) as therapeutic entzuendungshemmendes |
| 06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | CA2125192A1 A process for generating a structural and functional diversity in a peptide sequence |
| 06/24/1993 | CA2085828A1 Serpulina hyodysenteriae vaccine |
| 06/23/1993 | EP0548024A2 Aminosulphonic acid derivatives and process for their preparation |
| 06/23/1993 | EP0547689A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a T-cell stimulatory epitope |
| 06/23/1993 | EP0547681A2 Synthetic peptides comprising a cyclic HIV principal neutralizing determinant and a lipopeptide |
| 06/23/1993 | EP0547631A2 Antibody expression vector and antibodies produced thereby |
| 06/23/1993 | EP0547446A2 Vaccines based on modified bovine herpesvirus type I |
| 06/23/1993 | EP0547172A1 REGULATION OF T-CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
| 06/23/1993 | EP0547164A1 Methods for the diagnosis and treatment of diabetes |
| 06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
| 06/23/1993 | EP0547140A1 Immunosuppressant composition |
| 06/23/1993 | EP0547137A1 Homoconjugated immunoglobulins |
| 06/23/1993 | EP0547076A1 Cd58-specific monoclonal antibodies and their use |
| 06/23/1993 | EP0547059A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies. |
| 06/23/1993 | EP0272278B1 $i(D)-GL CONJUGATE THERAPY |
| 06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 06/22/1993 | US5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
| 06/22/1993 | US5221683 Diaminopyridine compounds and methods of use |
| 06/22/1993 | US5221618 Genetic detoxification of pertussis toxin |
| 06/22/1993 | CA1319337C Newcastle disease virus gene clones |
| 06/20/1993 | CA2085715A1 Aminosulfonic acid derivatives and processes for their preparation |
| 06/20/1993 | CA2058876A1 Cyclic hiv principal neutralizing determinant peptides |
| 06/19/1993 | CA2085084A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a t-cell stimulatory epitope |
| 06/19/1993 | CA2085083A1 Synthetic peptides comprising a cyclic hiv principal neutralizing determinant and a lipopeptide |
| 06/17/1993 | DE4240386A1 High purity, highly immunogenic hepatitis B vaccine - uses antigen isolated from human serum by affinity chromatography, induces antibodies in all subjects immunised |
| 06/17/1993 | DE4141970A1 Vaccine against AIDS, bilharziosis and tuberculosis - comprises BCG coated with partly oxidised polysaccharide(s), which are coated with viral or parasitic antigens or synthetic epitope(s) |
| 06/17/1993 | DE4141741A1 Vaccination against HIV infection - by administration of smallpox vaccine and para immunity inducers e.g. para-myxovirus or herpes virus |
| 06/16/1993 | EP0546787A2 Expression of specific immunogens using viral antigens |
| 06/16/1993 | EP0546634A2 Tumor associated monoclonal antibody 88BV59 |
| 06/16/1993 | EP0546349A2 PRP overproducing haemophilus influenzae strain |
| 06/16/1993 | EP0546156A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 06/16/1993 | EP0546126A1 Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome |
| 06/16/1993 | EP0546122A1 Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies |
| 06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 06/16/1993 | EP0546081A1 New insulin-like growth factor binding protein (igfbp-4) |
| 06/16/1993 | EP0546076A1 Use of anti-ICAM antibodies in the manufacture of a medicament FOR TREATING ENDOTOXIN SHOCK |
| 06/16/1993 | EP0546054A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 06/16/1993 | EP0546031A1 Enterovirus peptides |
| 06/16/1993 | EP0406259B1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
| 06/16/1993 | CN1073208A Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor |
| 06/16/1993 | CN1073180A Producing technology for pineapple seed agglutinin |
| 06/16/1993 | CN1073161A Endothelin receptor antagonists |
| 06/16/1993 | CN1021257C Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 06/15/1993 | US5220014 Inhibit protein synthesis |
| 06/15/1993 | US5219999 Immunoglobulin g and process for the production thereof |
| 06/15/1993 | US5219996 Recombinant antibodies and methods for their production in which surface residues are altered to cysteine residues for attachment of effector or receptor molecules |
| 06/15/1993 | US5219987 Sequential polypeptides endowed with immunological activity |
| 06/15/1993 | US5219749 Process for isolating and preparing purified chitin deacetylase |
| 06/15/1993 | US5219725 Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| 06/15/1993 | US5219579 Culture product of tumor tissue cells; cancer diagnosis, screening |
| 06/15/1993 | US5219577 Biologically active composition having a nanocrystalline core |
| 06/15/1993 | US5219567 Vaccine against herpes viruses |
| 06/15/1993 | US5219566 Immunoprophylactic polypeptides for schistosomiasis |
| 06/15/1993 | CA1319101C Rotavirus nucleocapsid protein with or without binding peptides as immunologic carriers for macromolecules |
| 06/14/1993 | CA2083542A1 Tumor associated monoclonal antibody 88bv59 |
| 06/13/1993 | WO1993011776A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/13/1993 | CA2124565A1 Method for inhibiting selectin-dependent adhesion of leukocytes and platelets by o-glycosylation modification |
| 06/12/1993 | CA2084180A1 Expression of specific immunogens using viral antigens |
| 06/12/1993 | CA2057387A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 06/10/1993 | WO1993011251A1 Recombinant viruses comprising artificial proteolytic cleavage site |
| 06/10/1993 | WO1993011250A1 Bicistronic viruses |
| 06/10/1993 | WO1993011238A1 Humanized b-b10, an anti-il2 receptor antibody |
| 06/10/1993 | WO1993011237A1 Cdr grafted humanised chimeric t-cell antibodies |